Miner Company
Routine Vaccines Okay For Now: Investment Implications Of The Court Decision
The federal court's halt of proposed childhood immunization schedule changes preserves stable, high-volume revenue streams for major vaccine manufacturers like Pfizer, Merck, Moderna, GSK, and Sanofi. Blocking the policy reversal maintains routine coverage for 17 diseases, safeguarding predictable insurance reimbursement and near-universal pediatric vaccine uptake.
The federal court's halt of proposed childhood immunization schedule changes preserves stable, high-volume revenue streams for major vaccine manufacturers like Pfizer, Merck, Moderna, GSK, and Sanofi. Blocking the policy reversal maintains routine coverage for 17 diseases, safeguarding predictable insurance reimbursement and near-universal pediatric vaccine uptake.